Il y a eu 50 transactions d'initiés récentes enregistrées pour Corcept Therapeutics Incorporated (CORT), dont 24 achats et 20 ventes. Le total des achats d'initiés s'élève à $56.64M et le total des ventes d'initiés à $7.55M.
Les initiés notables ayant une activité récente comprennent Belanoff Joseph K, Wilson James N, Guyer William. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CORT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-25 |
Belanoff Joseph K |
Chief Executive Officer |
Vente Informative |
26,198 |
$50.07 |
$1.31M |
2,918,326 |
| 2026-03-20 |
Wilson James N |
Director |
Don (Donné) |
4,000 |
- |
- |
1,102,532 |
| 2026-03-20 |
Guyer William |
Chief Development Officer |
Vente Informative |
11,767 |
$36.01 |
$423.73K |
2,231 |
| 2026-03-17 |
Baker G Leonard Jr |
Director |
Achat Informatif |
75,782 |
$33.00 |
$2.5M |
1,122,413 |
| 2026-03-13 |
Mahoney David L |
Director |
Exercice d'Options (Vente) |
30,000 |
$5.86 |
$175.8K |
- |
| 2026-03-13 |
Wilson James N |
Director |
Don (Donné) |
28,000 |
- |
- |
1,106,532 |
| 2026-03-04 |
Guyer William |
Chief Development Officer |
Vente Informative |
8,233 |
$35.99 |
$296.35K |
2,231 |
| 2026-03-03 |
Robb Gary Charles |
Chief Business Officer |
Retenue Fiscale RSU |
121 |
$35.97 |
$4.35K |
79,503 |
| 2026-03-03 |
Mokari Atabak |
Chief Financial Officer |
Retenue Fiscale RSU |
96 |
$35.97 |
$3.45K |
15,257 |
| 2026-03-03 |
Maduck Sean |
See Remarks |
Retenue Fiscale RSU |
110 |
$35.97 |
$3.96K |
8,977 |
| 2026-03-03 |
Lyon Joseph Douglas |
See Remarks |
Retenue Fiscale RSU |
89 |
$35.97 |
$3.2K |
11,230 |
| 2026-03-02 |
Robb Gary Charles |
Chief Business Officer |
Attribution de RSU |
499 |
$35.97 |
$17.95K |
79,125 |
| 2026-03-02 |
Mokari Atabak |
Chief Financial Officer |
Attribution de RSU |
397 |
$35.97 |
$14.28K |
14,956 |
| 2026-03-02 |
Maduck Sean |
See Remarks |
Attribution de RSU |
454 |
$35.97 |
$16.33K |
8,633 |
| 2026-03-02 |
Lyon Joseph Douglas |
See Remarks |
Attribution de RSU |
398 |
$35.97 |
$14.32K |
10,921 |
| 2026-03-02 |
Guyer William |
Chief Development Officer |
Attribution de RSU |
498 |
$35.97 |
$17.91K |
1,733 |
| 2026-02-27 |
Belanoff Joseph K |
Chief Executive Officer |
Attribution de RSU |
460,000 |
$35.70 |
$16.42M |
460,000 |
| 2026-02-27 |
Robb Gary Charles |
Chief Business Officer |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Mokari Atabak |
Chief Financial Officer |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Hunt Hazel |
Chief Scientific Officer |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Maduck Sean |
See Remarks |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Lyon Joseph Douglas |
See Remarks |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-27 |
Guyer William |
Chief Development Officer |
Attribution de RSU |
140,000 |
$35.70 |
$5M |
140,000 |
| 2026-02-24 |
Wilson James N |
Director |
Exercice d'Options |
100,000 |
$3.88 |
$388K |
- |
| 2026-02-09 |
Hunt Hazel |
Chief Scientific Officer |
Exercice d'Options (Vente) |
150,000 |
$3.88 |
$582K |
- |
| 2026-02-03 |
Guyer William |
Chief Development Officer |
Vente Informative |
20,000 |
$40.87 |
$817.33K |
1,235 |
| 2026-01-27 |
Baker G Leonard Jr |
Director |
Exercice d'Options (Vente) |
25,000 |
$10.50 |
$262.5K |
- |
| 2026-01-08 |
Maduck Sean |
See Remarks |
Don (Donné) |
34,000 |
- |
- |
5,147 |
| 2026-01-06 |
Guyer William |
Chief Development Officer |
Vente Informative |
20,000 |
$35.18 |
$703.66K |
1,235 |
| 2026-01-01 |
Baker G Leonard Jr |
Director |
Don (Donné) |
- |
- |
- |
3,308,303 |
| 2025-12-24 |
Belanoff Joseph K |
Chief Executive Officer |
Don (Donné) |
243,154 |
- |
- |
- |
| 2025-12-24 |
Robb Gary Charles |
Chief Business Officer |
Exercice d'Options (Vente) |
145,000 |
$3.88 |
$562.6K |
- |
| 2025-12-12 |
Wilson James N |
Director |
Autre (Achat) |
200,000 |
- |
- |
200,000 |
| 2025-12-02 |
Mokari Atabak |
Chief Financial Officer |
Retenue Fiscale RSU |
118 |
$79.78 |
$9.41K |
14,559 |
| 2025-12-02 |
Maduck Sean |
See Remarks |
Retenue Fiscale RSU |
135 |
$79.78 |
$10.77K |
8,179 |
| 2025-12-02 |
Lyon Joseph Douglas |
See Remarks |
Retenue Fiscale RSU |
110 |
$79.78 |
$8.78K |
10,523 |
| 2025-12-02 |
Guyer William |
Chief Development Officer |
Don (Donné) |
787 |
- |
- |
- |
| 2025-12-01 |
Robb Gary Charles |
Chief Business Officer |
Attribution de RSU |
224 |
- |
- |
14,058 |
| 2025-12-01 |
Mokari Atabak |
Chief Financial Officer |
Attribution de RSU |
178 |
$79.78 |
$14.2K |
14,499 |
| 2025-12-01 |
Maduck Sean |
See Remarks |
Vente Informative |
20,000 |
$79.52 |
$1.59M |
7,904 |
| 2025-12-01 |
Lyon Joseph Douglas |
See Remarks |
Vente Informative |
5,000 |
$79.53 |
$397.63K |
10,277 |
| 2025-12-01 |
Guyer William |
Chief Development Officer |
Attribution de RSU |
224 |
$79.78 |
$17.87K |
224 |
| 2025-06-16 |
Robb Gary Charles |
Chief Business Officer |
Vente Informative |
3,185 |
$70.77 |
$225.4K |
13,364 |
| 2025-06-10 |
Baker G Leonard Jr |
Director |
Attribution de RSU |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Mahoney David L |
Director |
Attribution de RSU |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Wilson James N |
Director |
Attribution de RSU |
25,000 |
$72.27 |
$1.81M |
25,000 |
| 2025-06-10 |
Swisher Daniel N Jr |
Director |
Vente Informative |
2,200 |
$70.61 |
$155.34K |
- |
| 2025-06-10 |
Alton Gregg H |
Director |
Attribution de RSU |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Park Kimberly |
Director |
Attribution de RSU |
15,000 |
$72.27 |
$1.08M |
15,000 |
| 2025-06-10 |
Cannon Gillian |
Director |
Attribution de RSU |
15,000 |
$72.27 |
$1.08M |
15,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
